Your browser doesn't support javascript.
loading
Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations.
Kuzbari, Z; Bandlamudi, C; Loveday, C; Garrett, A; Mehine, M; George, A; Hanson, H; Snape, K; Kulkarni, A; Allen, S; Jezdic, S; Ferrandino, R; Westphalen, C B; Castro, E; Rodon, J; Mateo, J; Burghel, G J; Berger, M F; Mandelker, D; Turnbull, C.
Afiliação
  • Kuzbari Z; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Bandlamudi C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Loveday C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. Electronic address: https://twitter.com/LovedayChey.
  • Garrett A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. Electronic address: https://twitter.com/DrAliceGarrett.
  • Mehine M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • George A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.
  • Hanson H; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; South West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Snape K; South West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK. Electronic address: https://twitter.com/genetikos.
  • Kulkarni A; South East Thames Regional Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: https://twitter.com/Anju__Kulkarni.
  • Allen S; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Jezdic S; Scientific and Medical Division, European Society for Medical Oncology, Lugano, Switzerland.
  • Ferrandino R; Scientific and Medical Division, European Society for Medical Oncology, Lugano, Switzerland.
  • Westphalen CB; Department of Medicine III and Comprehensive Cancer Center (CCC Munich LMU) University Hospital, LMU Munich, Munich, Germany.
  • Castro E; Genitourinary Cancers Translational Research Group, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain. Electronic address: https://twitter.com/Ecastromarcos.
  • Rodon J; Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Burghel GJ; North West Genomic Laboratory Hub, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: https://twitter.com/BurghelG.
  • Berger MF; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Mandelker D; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: education@esmo.org.
Ann Oncol ; 34(3): 215-227, 2023 03.
Article em En | MEDLINE | ID: mdl-36529447

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
...